SANGUINE CORP. (SGNC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: omegaman who wrote (375)	6/12/1998 1:20:00 PM
From: Andrew H	Read Replies (2) of 5402

LOL, guys, do I sound like I am long this stock? I am neither long nor short, rather curious and skeptical. What difference does it make if I am long? One who is neither long nor short should be able to provide a more objective and less biased view... Look, the blood substitute market is large and lucrative. This company may have a product that will eventually be commercialized. However, only a very small percentage of trial products ever get through the FDA--the average cost is something like 200+ million dollars to get all the way through P3 and the chances are small. Thus, at over 22M market cap, given the very significant risks involved, it appears to me that SGNC is more than fully valued. That said, sure it could go higher with enough support. But its going to be a very long time before this company has any product revenues, if ever. Chances are against it. That's all I am saying. When you have a OTCBB stock with a market cap of over 22M and poor chances of ever having a commercialized product, investors should be very careful.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next